U-Blot® Research Grade SabatolimabCat. No. WA3496Request quote
Size: 50ug/100ug
Overview
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade SabatolimabCat. No. WA3496U-Blot® Research Grade ruzaltatugCat. No. WA3495Request quote
Size: 50ug/100ug
U-Blot® Research Grade RuxoprubartCat. No. WA3494Request quote
Size: 50ug/100ug
U-Blot® Research Grade RuplizumabCat. No. WA3493Request quote
Size: 50ug/100ug
U-Blot® Research Grade RunimotamabCat. No. WA3492Request quote
Size: 50ug/100ug
U-Blot® Research Grade RulonilimabCat. No. WA3491Request quote
Size: 50ug/100ug
U-Blot® Research Grade rugecitideCat. No. WA3490Request quote
Size: 50ug/100ug
U-Blot® Research Grade Rozibafusp alfaCat. No. WA3489Request quote
Size: 50ug/100ug
U-Blot® Research Grade RozanolixizumabCat. No. WA3488Request quote
Size: 50ug/100ug
U-Blot® Research Grade RovelizumabCat. No. WA3487Request quote
Size: 50ug/100ug
U-Blot® Research Grade RovalpituzumabCat. No. WA3486Request quote
Size: 50ug/100ug
U-Blot® Research Grade RosopatamabCat. No. WA3485Request quote
Size: 50ug/100ug
REQUEST A QUOTE
EMAILinfo@mail.ucallm.com
PHONE+(1)-866-986-9598
ONLINE FORMOnline Quote Submission
X+(1)-866-986-9598